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I. INTRODUCTION 
Reverse transcriptase is an enzyme of central impor- 
tancc in rhc replication of HIV, the causative agent of 
AIDS [l]. Part of the HIV-I polgenecodes for a p66RT 
subunit that is cleaved at the C-terminal region by the 
HIV protcase to give a p66/p51 heterodimcr, the form 
of RT observed in virions f2), An RNaseH domain has 
been identified within the last 120 amino acids of the C- 
terminal region of the p66 subunit by sequence analysis 
[3] and functional studies [4]. 
We have previously described immunoaffinity 
chromatography of RT using immobilized monoclonal 
antibodies raised to HIV-I RT [5]. Elution of RT from 
these columns requires vigorous conditions which may 
have deleterious effects on enzyme structure. This 
together with the C-terminal heterogeneity observed in 
these preparations [6], may contribute to the disorder 
observed in three different crystal forms of RT when ex- 
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HIV-l, human immunodeficiency virus type 1; RT, reverse transcrip- 
tase; p66RT(KVL), p66RT(EEF), p5 I RT(ETF), p5 I RT(EEF), RTs 
with apparent molecular wts of 66 kDa and 51 kDa with the C- 
terminal amino acid sequence according to the single letter code; 
plSRNaseH(EEF), ribonucleaseH with apparent molecular WC of 
f5 kDa with the Gtcrminai amino acid sequence according to the 
sinde letter code; PFA, phosphonoformate; SDS-PACE, sodium 
dodecylsulphate/polyacrylamide gel electrophoresis; RTMab3, 
RTMabE, monoclonal antibodies raised against reverse transcriptase; 
IIPTG, isopropyl-,8-D-thiogalactopyranoside 
amincd in an X-ray beam [7]. We thus wished to devise 
a mild isolation procedure which could produce protein 
with an intact C-terminus, 
The work of Wehland et al, [8] on the detailed map- 
ping of the amino acid sequence requirement for the 
binding of m-tubulin to the monoclonal antibody 
YL1/2 [9] showed that an essentially linear epitope was 
located at the C-terminus OF the polypeptide chain. 
There was a requirement for a C-terminal aromatic 
residue (either tyrosine or phenylalanine) containing a 
free carboxyl group, preceded by an acidic residue 
(glutamic or aspartic acid). A further adjacent acidic 
residue greatly increased binding, It was also 
demonstrated that the loss of the C-terminal aromatic 
residue abolished the binding of cr-tubulin as well as 
related peptides to the YL1/2 antibody [8]. We 
therefore reasoned that incorporation of this epitope in- 
to HIV RT and RNaseH could afford a method of puri- 
fying these proteins with a homogeneous C-terminus 
using a simple peptide elution procedure from columns 
of immobilized YLl/:! antibody. Incorporation of this 
a-tubulin epitope into p66RT and RNaseH can be 
achieved by mutating the C-terminus from Lys-Val-Leu 
to Glu-Glu-Phe. The site of HIV protease cleavage of 
the p66RT subunit has been shown to be between a Phe 
and Tyr giving a ~51 subunit with a C-terminal se- 
quence of Glu-Thr+he [IO]. Therefore only a single 
change of Thr to Glu is required to incorporate the C+ 
tubulin epitope at the C-terminus of the ~51 polypep- 
tide. In changing the natural amino acid sequence of a 
protein there is the possibility of changing the biological 
characteristics of that protein. It has, however, 
previously been shown that the C-terminus of HIV- 1 RT 
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pricnctr incarpamtin$ AU4 and flindlll twitrictian xlterat the 5’ and 3, I 1 hrr@misn qfp58A 7’@%+F) and p$lB T’@EF) 
3” cndr, resprr~lvcly~ The 3tN bp Iral$mcnr tibtalnrd was cluncd into p66RTCEEF) in a bactcri.wl extract wns rmmvcd by 
pT7-7 cantainin~ the T7 RNA p~lymarar~ promo~rr and H 410 bp 
rlr”kt/~~ili~~dtll f+r$tnant sub-elonctl into Mllmpl9 for rcqueneln@. 
pa~ge through n YLlI24ephmese under low ~alr ean- 
ditlms. After wnshing in running buffer, the column 
7.2, E,q.wsslm of p~l,v~a~Yi&rr run/dnlrrg rhr Gh&hc+%s mnorV ~“(1s CIUECCI with 5 mM Asp-Phe (Fig. I). By contr~$t, 
High lcvcl cxprerrlan af the rerornbinttnt pt%RT(REP) rntl rt~ protein was: cluted with either Glu-Gju or Asg- 
p5lKT(EEF] and RT extraetien were curried out II% described Phc(BMe). Analysis of the ctuted fractions on SDS- 
grevin;usly [la). Thr? extract was tlialyaed into $0 mM MaCl, 50 mM 
Trls-k-ICI, pil 7.5, before loading on the VLI/25Scphrroxc cahtmn. 
PP&E @~cls showed rhc peak eluting with AtpPhe was 
For expression of rhc recombinant plSRNe&i(E.EF), the ~17-7 lrrrgrly p66RI’ (Fig. 2), The small amount of pSlRT 
plarmid was used IQ tranarorm &: roli strain t3621 DE3 lnetq [NJ. present ia due to proteolysis 8s has been observed 
Waetrrin were Urown in 2XTY medium with ampicillin and previously [6). RT with the normal Cmminus, 
tctraqyelinc delcrtisn until ihc 043,p~ equellsd 0.5 and then induction p66RT(KVL), did not bind to the Ytt/2-Scpharose col- 
wits carried OIII with IPTB (I WI). Cells were harvested alter 4 h by 
pellcting.(lOOOO rpm, 5 min, J*C)rnd rcat5pcndctl in $0 mM NtCl, 
umn, neither did pQ(SRT(EEF) that had been digested 
50 mM TriGiCI, pW 7.5, and disrupted by sonication. Cell debris with cnrbaxypeptidnse A. ~51 RT(EEF) was purified as 
was remavcd by eentrifugatian RI 40000 rpm for IO min before ap- described for p66RT(EEF). A comparison of specific 
pkation ro the YLI/2&pharose columns. activities, K,,,s for dTTP, &as for PFA far normal and 
2.3. Preperariorr of YL1/2 Sepharose urtribacly eolurtrn mutated p66 or p51 forms of RT arc shown in Table 1. 
YL1/2 rat ascites fluid was obtained from Scrotec (QxTord, UK). 
The RNaseH activity of pBSRT(EEF) and p66RT(KVL) 
tgGs were purified from this by ammonium sulfate fractionation and are shown in Fig. 3, An alternative clurion groccdu,re 
ion exchange on DEAE-cellulorc (DE52, Whatman) and coupled IO was co wash the YLl/Z-Scpharose column with 0.2 M 
CNRr-activated Scpharorc (I g/IO mg of IgG) following the 
manufacturers’ instructions (Pharmacia), Columns of 
YLl/l-Se&arose were equilibrated in 50 mM NaCI, 50 mM Tris- 
NCI, pH 7.5. Elution conditions are described in section 3. AspsPhc, 
Clu-Glu and Asp-Phe (OMc) were obtained from Sigma. 
2.4. Purificrrtion of p66RT(KYL) unrl pSIRT(ETF) 
These were purified on RTMnb% and RTMab3-Sepharose im- 
munoaffinity columns as described previously [5! and protein concen- 
tration of purified protein deterrnined based on ODZUO of I = 
0.5 nig/ml, 
2.5. Assay for reverse transcriprase 
Assays were carried out using poly(rA)-(dT)ls (Pharmacia) as 
template/primer with the incorporation of [‘W]dTTP (Amersham) as QD280 
described previously 1121. f& measurements for dTTP were determin- 
ed using saturating levels of rA-dT (50/1g/ml) and varying dTTP. 
1Cst1 determinations for phosphonoformate (PFA) were measured at 
a dTTP concentration of 5 PM. Kinetic data were analysed using non. 
linear least-squares 1131. 
2.6. Amy of RIVaseH 
RNaseH assays were carried out at 37OC for 15 min in 50 mM Tris- 
HCl, pM 8.0, 5 mM MgClz, SO mM KCI, 1 mM DTT plus 
[%]RNA/DNA hybrid containing 2 x lo5 cpm (Ml3 synthesised us- 
ing RNA polymerase and [“S]UTP). Samples were precipitated on 
glass fibre filters (Whatman GF/C) using 5% TCA and washed in the Time 
same reagent. Thermal inactivation studies at 45% were carried out 
as described previously [ 141. Fig. 1. Elution profile of p66RT(EEF) from YLl/Z-Sepharose. The 
column was run as described in section 2 and eluted as folIows: (a) 
2.7. SDS-PAGE and Weslm blotting 5 mM Glu-Glu; (b) running buffer; (c) 5 mM Asp-Phe(OMe); (d) 
These were performed using a Tris-glycine buffer system [IS]. running buffer; (e) 5 mM Asp-Phe. 
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KCI IO remove non-specifically bound protein and ICI 
eIute the RT with 1 M KCI, 
8. Thermal lnocrivation (45OC1 
3.2. Digestion of ptSAT(EEF) with HIV protease and 
&he identification of plSRNaseH(EEF) 60 
p66RT(EEF) purified on Y LI /2-Sepharose as 
described above was subjected to proteolysis with 
homogeneous HIV proteasc. Analysis of this on SDS- 
PAGE gels followed by Western blots probed with -i 40 
either YL1/2 or RTMab3 and RTMab$ showed that a % ‘ij 
pl5 polypeptide can be identified using the YL1/2 (Y- L -0 
tubulin antibody but not with RTMab3 or RTMab8 2 
(Fig, 4). This result indicated that it might also be possi- 
ble to purify the 15K RNaseH domain using the ap- 
g 20 
preach described above. 
3.3. Purification of pISRNaseH(EEF) on YLl/,?- 
Sepkarose 
plSRNaseH(EEF) was purified from a crude E. coli 0 20 40 60 
extract to >95% purity in a single step on Time (mins) 
YLl/Z-Sepharose using the procedure described above. 
Only low levels of RNaseH activity were detected for Eig. 3, Comparison of RNascH activity of p66RT(EEF) and 
the pl5 polypeptide which was at best lOOO-fold lower p66RT(KVL). (A) As a function of enzyme concentration, (l3) 
than for the corresponding p66(EEF)RT protein. Thermal inactivation as a function of lime. 
Table I 
Comparison of the kinetic properties of normal and mutated RT 
Mol. wt. 66K 51K 
C-terminus: Lys-Val-Lcu Glu-Glu-Phe Glu-Thr-Phr Glu-Glu-Phe 
Specific activity 
(nmol/min/mg of 
protein) 424 f 16 496 f 29 23 5 4 113 f. 35 
K,,, dTTP f,uM) 5.6 A 0.4 8.2 ct 0.3 9.5 zk 2.3 ii,7 zt 2.5 
ICso PFA @M) 0.44 I 0.03 0.35 Lk 0.05 0.3 i 0.08 0,ss rk 0.1 
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15K- 
Fig, 5. SDS-PAGE.of RNasfH run on YLl/2-Scphorosc, 1 = column 
load of bacterial extract containing p15RNascH(EEl:); 2 = run’ 
through; 3,4 = clution with Asp+Phc; 5 = mol. wt. markerS. 
4. DISCUSSION 
The work dc$cribcd here shows that engineering 
HIV-1 RT and RNaseH by site-directed mutagenesis to 
incorporate the C-terminal sequence Glu-Glu-Phe 
means that these proteins can bc recognized by a 
monoclonal antibody, YL1/2, originally raised to a dif- 
ferent protein, cr.tubulin. Using YL1/2 immobilized on 
Scpharose provides a method for the rapid single step 
purification of p66 and pSlRT, and pl5RNaseH con- 
taining the Glu-Glu-Phe epitope. Using Asp-Phe to 
elute the columns gives very mild conditions compared 
to those normally required to elute antibody columns 
[51. 
From the epitope mapping of YL1/2 it would be 
predicted that the proteins bound to the YL1/2 column 
would contain an homogenous C-terminus since a C- 
terminal aromatic residue is required 681. The failure of 
proteins to be eluted by Glu-Glu or’by Asp-Phe(OMe) 
is consistent with this., In addition we have shown that 
when p66RT(EEF) is subjected to carboxypeptidase A 
digestion, binding to the YLl/Z-Sepharose column is 
eliminated. The specificity for carboxypeptidase A is 
such that aromatic residues are readily removed but 
acidic residues are only slowly released; it has been 
shown that carboxypeptidase A digestion pf a-tubulin 
only releases the C-terminal tyrosine [16]. We are cur- 
rently studying the crystallization properties of the RTs 
purified on YL1/2-Scpharose to ascertain whether 
crystal order is improved. 
Our determination of various activity measurements 
for wild-type and mutated RTs indicates that specific 
activities, K,,,s for dTTP and ICsos for PFA are essen- 
tially unchanged as was the RNaseH activity of 
p66RT(EEF) compared to p66RT(KVL). Thus in: 
traducing these mutations does not affect these proper- 
ties as would be predicted from earlier work on amino 
acid deletions from the C-terminus which had no effect 
on enzyme activity [5,1 I]. 
Our previous attempts to identify the pl§RNaseH 
domain released after proteolysis of the p66RT subunit 
have proved unsuccessful [7]. In this study the digestion 
of p66RT(EEF) with HIV protease gave a pl5 polypep- 
tide that could be identified on Western blots probed 
with Yl1/2 anti cu-tubulin antibody but not by 
RTMabS, an antibody previously shown to recognize 
an epitope in the RNaseH region [S]. This could in- 
301 
dleate that a eonformational ehawge oeeufs in the plb (4) blmrm, J,, &helxr, f., McRwl, W. rrd Msrolliny, K, (IfftrW) 
pcrlypqitidc wlrcn It ia released !FoRI rhc! pa subunit. &MIX3 I‘ 1, xw-ZdZ. 
High level expression of the. pISRNw~aeH domain wwli f3l Tirdala, M., &Ii, P., Lwdw, If,, Pwllw. 0,J.M.. Dwby, t;i* 
thieved using the T7 system. Activity mesrsurement i -
wx! Pewrll, K. (i98s%%) J, Viral. 62, 3~2*3~~. 
dieares that the p~~RN~~c~(~~~) has only IIIQWlth of 
161 ~&WC, D.M., Airleon. A.. Iradley, C.R., ihrby, Q.bie, biftl~?, 
IkA., Pwrll, K.L., Purllay, B,J.M., “PlsLlrs, hi. #nd 
the RNaM-f activity of p66RT(EEP), This agrees with b~a~nnwrw. B.K. (1481) Bkhcmbrfy 27, ~~~~~~~~~. 
Beccm et al, (1990) [I71 who Fcporte$ that the 17) RnmmCrr* D.Ee,, Pow+zll, K.L., Larder, B.A., Drrb& G,, 
bacterially expressed p1SRNaM-I domain had a very birti~, DJM,, Tlrdrhh M., I,owe. WI., awrr, D.1., Juncr, 
low level RNaacH activity. This could indicate that the 
B.Y., Taylw, a.t.8, Cs~lr~nan, E,F., archt, R, and Phlllipw, 
b *, (l99U) In: Ure al Xmy ~r~~t~ll~~p~~h~ 311 thr! RMyn d 
isolated ~15 golypeptide does not have significance 21s Anrivirrl Agcnla (Law, 0. and Air, Q. cd%) pp, 309-319, 
wn RNaseH in the virus life cycle. Ar~demle Prenr, New Ynrk. 
The use of YLl/ZSepharosc to purify proteins with 18) Wchland, J., Schrrrdcr, ti1.e. and Wcbor, K-. (19&i) EMU0 J, 3, 
the C-terminus mutated to incorporate the Glu~Glu-Phe 
I x8- I3(10. 
l9) Kilmar~in, J.V., Wri&l, R, and Mllscin, 6, (19@2) J. Cell Biol. 
or related motif thus could have wide application for 93, J76-582, 
single step purification of proteins in which the C- [to) Mixrahi, V., LsLawux, 8,M., Miles, L.M., Ncycrr, c*A. #r&i 
terminus is not critical for activity. In addition, incor- Dckm~ch, C. (1989) Arch. Diochem. Biophyx. 273, 347-358. 
poration of this cpitopc provides an immunologiea~ (I 11 Hiri, A,, McGill, C. and Hu$hcs, S.H. (t98fl) Prec. t&111, Acad. Sci, USA 8% 1218-1222, 
marker for assessing the expression of recombinant IllI Lr\rdcrl t3., Purifoy, D,, Pawcll, K. and Darby, 0. (1967) 
proteins. EMU0 Y. G, 3133-313’2. 
1131 Srammcrx, D.K., Ditnn. J.Q., Hrrrio, C.J. nntl Sn~ith, D,R. 
REFERENCES 
(1987) Arch. Biochcm, Biophyb. 258, 413-428. 
1141 Tirdalc, M., Schulzc, T., Lnrdcr, B,A. nnd Moclling, Ic. (199L) 
[I] &we-Sinoursi, F.. Chcrmnnn, J.C., Rcy, F., Nugeyre,, M-T., 
J. Ckn, Viral. 72, 59-66. 
Charmawl, S., Grucst, J., DPU~UCI, C., Axicr-Blin, C., 
[IS] Lacmmli, U,K. (1970) Mnrurc 227, 680-685. 
116) Rabin, D, and Flrvin, M, (1977) J. Cell. Viol. 73, 492-504. 
Vcxincr-Bun, F., Rounioux, C,, Rozcnbautn, W. oncl 
Monragnicr, L. (1983) Science 220, 868-871, 
(17) Bcrcrm, S,. Claw, ci., Qroncnborn, A., Karktrom, A,, Stahl, 
[2] Di Mnrro Vcroncsc, F., Copeland, T.D., De Vito. A.L., 
S,J., Wilson, SW. and Winglficld, P.T, (1990) FEDS Left. 270, 
76-80, 
Rshmnn, R,, Orosrlan, S,, Gallo, R.C. and Snrnyndhnrnn, 
M.G. (1986) Science 231, 1289-1291. 
il8] Lowe, P.N., PQC, M.J., Bradley, S,, Rhode%, S,, Sydenhrm, 
13) Johnson, MS., McClure, M.A,, Feng, D..F., Gray, I. nnd 
M., Paterson, t-i. nnclSkinnrr, R.H. (1991) J. Viol. Chem. 266, 
1672-1678. .,.. _, . ..__. 
